Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Acute Myeloid Leukemia · Narcolepsy · JAZZ

Jazz Pharmaceuticals Ireland

Jazz Pharmaceuticals Ireland Limited

Jazz Pharmaceuticals Ireland clinical programs — 208 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Waterloo Exchange, Waterloo Road, Dublin, 4, IE HQ
2003 Founded
3,631 Employees
Public company Type
JAZZ · NYSE Ticker
Company details
Status
Public
HQ
Waterloo Exchange, Waterloo Road, Dublin, 4, IE
Founded
2003
Employees
3,631
Programs
208
Drugs
91
Patents
89
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Jazz Pharmaceuticals Ireland projects

208 ClinicalTrials.gov programs sponsored by Jazz Pharmaceuticals Ireland.

Jazz Pharmaceuticals Ireland has 208 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

208 programs

Clinical programs

Page 1 of 5

  1. Atezolizumab

    Jazz Pharmaceuticals Ireland Limited

    Small-Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  2. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus Infection

    phase 3 small molecule completed

    1 trial

  3. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    CMV

    phase 3 small molecule completed

    1 trial

  4. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Disease

    phase 3 small molecule terminated

    2 trials

  5. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Double-stranded DNA Virus

    phase 3 small molecule completed

    1 trial

  6. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    High Risk Acute Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  7. Cannabidiol (CBD)

    Jazz Pharmaceuticals Ireland Limited

    Clinical High Risk for Psychosis (CHR)

    phase 3 small molecule active

    1 trial

  8. Cytarabine

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  9. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Hepatic Veno-Occlusive Disease

    phase 3 small molecule completed

    2 trials

  10. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Severe Hepatic Veno-Occlusive Disease

    phase 3 small molecule completed

    1 trial

  11. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Veno-occlusive Disease

    phase 3 small molecule completed

    2 trials

  12. Dociparstat

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 3 small molecule terminated

    1 trial

  13. Dociparstat sodium

    Jazz Pharmaceuticals Ireland Limited

    Coronavirus Disease 2019 (COVID-19)

    phase 3 small molecule terminated

    1 trial

  14. Dordaviprone (ONC201)

    Jazz Pharmaceuticals Ireland Limited

    H3 K27M

    phase 3 small molecule active

    1 trial

  15. Everolimus

    Jazz Pharmaceuticals Ireland Limited

    Diffuse Intrinsic Pontine Glioma

    phase 3 small molecule active

    1 trial

  16. GW-1000-02

    Jazz Pharmaceuticals Ireland Limited

    Pain

    phase 3 small molecule completed

    3 trials

  17. GW-1000-02

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis

    phase 3 small molecule completed

    4 trials

  18. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Infantile Spasms

    phase 3 small molecule completed

    2 trials

  19. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 3 small molecule completed

    5 trials

  20. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Tuberous Sclerosis Complex

    phase 3 small molecule completed

    2 trials

  21. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Seizure in Participants With Tuberous Sclerosis Complex

    phase 3 small molecule terminated

    1 trial

  22. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Seizures Associated With EMAS

    phase 3 small molecule terminated

    1 trial

  23. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Rett Syndrome

    phase 3 small molecule terminated

    2 trials

  24. GWP42003-P 20 mg/kg/Day Dose

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 3 small molecule completed

    3 trials

  25. IM JZP-458

    Jazz Pharmaceuticals Ireland Limited

    Acute Lymphoblastic Leukemia

    phase 3 small molecule completed

    1 trial

  26. JZP-110

    Jazz Pharmaceuticals Ireland Limited

    Obstructive Sleep Apnea

    phase 3 small molecule completed

    3 trials

  27. JZP-110

    Jazz Pharmaceuticals Ireland Limited

    Narcolepsy

    phase 3 small molecule completed

    3 trials

  28. JZP-258

    Jazz Pharmaceuticals Ireland Limited

    Idiopathic Hypersomnia

    phase 3 small molecule completed

    1 trial

  29. JZP-258

    Jazz Pharmaceuticals Ireland Limited

    Narcolepsy With Cataplexy

    phase 3 small molecule completed

    1 trial

  30. JZP598-302

    Jazz Pharmaceuticals Ireland Limited

    BTC - Biliary Tract Cancer

    phase 3 small molecule active

    1 trial

  31. JZP598-303

    Jazz Pharmaceuticals Ireland Limited

    Metastatic HER2-positive breast cancer

    phase 3 small molecule active

    1 trial

  32. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Spasticity With Multiple Sclerosis

    phase 3 small molecule terminated

    1 trial

  33. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Pain

    phase 3 small molecule completed

    3 trials

  34. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Post-Traumatic Stress Disorder

    phase 3 small molecule terminated

    1 trial

  35. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis (MS)

    phase 3 small molecule terminated

    1 trial

  36. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Spasticity in Participants With Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  37. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Palliative Care

    phase 3 small molecule completed

    1 trial

  38. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  39. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Pain

    phase 3 small molecule completed

    6 trials

  40. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Cerebral Palsy

    phase 3 small molecule completed

    1 trial

  41. Sativex®

    Jazz Pharmaceuticals Ireland Limited

    Spasticity

    phase 3 small molecule completed

    3 trials

  42. Sativex®

    Jazz Pharmaceuticals Ireland Limited

    Detrusor Overactivity

    phase 3 small molecule completed

    1 trial

  43. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Fibromyalgia

    phase 3 small molecule completed

    1 trial

  44. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Binge Eating Disorder

    phase 3 small molecule completed

    1 trial

  45. St Thomas

    Jazz Pharmaceuticals Ireland Limited

    Coronary Artery Stenosis

    phase 3 small molecule completed

    1 trial

  46. Tetrahydrocannabinol

    Jazz Pharmaceuticals Ireland Limited

    Pain, Postoperative

    phase 3 small molecule active

    1 trial

  47. Vyxeos

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukaemia

    phase 3 small molecule active

    1 trial

  48. Xyrem

    Jazz Pharmaceuticals Ireland Limited

    Narcolepsy

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Jazz Pharmaceuticals Ireland have?

208 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.